tradingkey.logo
tradingkey.logo
Pesquisar

NeuroOne Medical Technologies Corp

NMTC
Adicionar à lista de desejos
4.210USD
-0.390-8.48%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
36.29MValor de mercado
PerdaP/L TTM

NeuroOne Medical Technologies Corp

4.210
-0.390-8.48%

Mais detalhes de NeuroOne Medical Technologies Corp Empresa

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

Informações de NeuroOne Medical Technologies Corp

Código da empresaNMTC
Nome da EmpresaNeuroOne Medical Technologies Corp
Data de listagemNov 09, 2012
CEORosa (David A)
Número de funcionários17
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 09
Endereço7599 Anagram Dr
CidadeEDEN PRAIRIE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55344-7399
Telefone19524261383
Sitehttps://nmtc1.com/
Código da empresaNMTC
Data de listagemNov 09, 2012
CEORosa (David A)

Executivos da empresa NeuroOne Medical Technologies Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%

Detalhamento da receita

Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Merchant Adventure Fund LP
8.12%
Bleichroeder LP
7.73%
Bard Associates Inc.
3.56%
Perkins Capital Management, Inc.
2.85%
Vanguard Capital Management, LLC
2.70%
Outro
75.04%
Investidores
Investidores
Proporção
Merchant Adventure Fund LP
8.12%
Bleichroeder LP
7.73%
Bard Associates Inc.
3.56%
Perkins Capital Management, Inc.
2.85%
Vanguard Capital Management, LLC
2.70%
Outro
75.04%
Tipos de investidores
Investidores
Proporção
Investment Advisor
18.60%
Corporation
8.31%
Individual Investor
5.89%
Hedge Fund
3.86%
Investment Advisor/Hedge Fund
2.13%
Research Firm
0.18%
Venture Capital
0.17%
Bank and Trust
0.04%
Outro
60.82%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
58
2.36M
28.07%
-230.40K
2025Q4
52
16.89M
33.49%
-598.07K
2025Q3
51
17.15M
34.30%
+9.56M
2025Q2
52
13.28M
26.66%
+2.81M
2025Q1
54
11.51M
24.26%
+968.46K
2024Q4
55
12.46M
40.67%
+1.38M
2024Q3
55
11.22M
39.84%
+2.23M
2024Q2
51
10.72M
41.07%
+2.35M
2024Q1
52
11.45M
45.01%
+2.75M
2023Q4
57
9.37M
38.68%
+871.77K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Merchant Adventure Fund LP
4.20M
8.29%
--
--
Dec 31, 2025
Bleichroeder LP
4.00M
7.89%
--
--
Dec 31, 2025
Bard Associates Inc.
1.85M
3.64%
-4.00K
-0.22%
Dec 31, 2025
Perkins Capital Management, Inc.
1.47M
2.91%
+5.00K
+0.34%
Dec 31, 2025
Sio Capital Management, LLC
1.14M
2.25%
-1.22M
-51.71%
Dec 31, 2025
Renaissance Technologies LLC
763.03K
1.51%
+70.43K
+10.17%
Dec 31, 2025
Rosa (David A)
745.12K
1.47%
-71.33K
-8.74%
Feb 18, 2026
Geode Capital Management, L.L.C.
504.51K
1%
+7.68K
+1.54%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Apr 14, 2026
Merger
6→1
Data
Data ex-dividendo
Tipo
Proporção
Apr 14, 2026
Merger
6→1
KeyAI